Future studies should aim to clarify the precise molecular mechanisms linking S6K1 to necroptosis and explore whether S6K1 inhibitors can provide therapeutic benefits by preventing neuronal loss in AD. This evidence concerns the gene RPS6KB1 and Alzheimer disease.